Zobrazeno 1 - 10
of 201
pro vyhledávání: '"John T. Vetto"'
Autor:
Avani M. Kolla BPhil, Gerardo A. Vitiello MD, Erica B. Friedman MD, James Sun MD, Aishwarya Potdar MS, Hala Daou BS, Norma E. Farrow MD, Clara R. Farley MD, John T. Vetto MD, Dale Han MD, Marvi Tariq MD, Georgia M Beasley MD, Carlo M. Contreras MD, Michael Lowe MD, Jonathan S. Zager MD, Iman Osman MD, Russell S. Berman MD, Tracey N. Liebman MD, Jennifer A. Stein MD PhD, Ann Y. Lee MD
Publikováno v:
Cancer Control, Vol 28 (2021)
Background Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care. Objectives To analyze the clinicopathologic f
Externí odkaz:
https://doaj.org/article/57f410acb38d4768a497f22089e561a6
Autor:
Jonathan S. Zager, Brian R. Gastman, Sancy Leachman, Rene C. Gonzalez, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah I. Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The heterogeneous behavior of patients with melanoma makes prognostication challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk was previously developed. This study evaluates the GEP’s pr
Externí odkaz:
https://doaj.org/article/51ad8d737b2d423ab145b5125b6bb24a
Autor:
John T. Vetto
Publikováno v:
Journal of Investigative Surgery, Vol 32, Iss 2, Pp 162-163 (2019)
Externí odkaz:
https://doaj.org/article/e167fbca6da24c47bd3ad00b8c8b773a
Autor:
Adrienne B, Shannon, Cimarron E, Sharon, Richard J, Straker, Michael J, Carr, Andrew J, Sinnamon, Kita, Bogatch, Alexandra, Thaler, Nicholas, Kelly, John T, Vetto, Graham, Fowler, Danielle, DePalo, Vernon K, Sondak, John T, Miura, Mark B, Faries, Edmund K, Bartlett, Jonathan S, Zager, Giorgos C, Karakousis
Publikováno v:
Journal of the American Academy of Dermatology. 88:52-59
Sentinel lymph node biopsy is not routinely recommended for T1a cutaneous melanoma due to the overall low risk of positivity. Prognostic factors for positive sentinel lymph node (SLNTo determine factors associated with SLNPatients with pathologic T1a
Autor:
Carl-Jacob Holmberg, Lars Ny, Tina J. Hieken, Matthew S. Block, Michael J. Carr, Vernon K. Sondak, Christoffer Örtenwall, Dimitrios Katsarelias, Florentia Dimitriou, Alexander M. Menzies, Robyn PM. Saw, Aljosja Rogiers, Richard J. Straker, Giorgos Karakousis, Rona Applewaite, Lalit Pallan, Dale Han, John T. Vetto, David E. Gyorki, Emilia Nan Tie, Maria Grazia Vitale, Paulo A. Ascierto, Reinhard Dummer, Jade Cohen, Jane YC. Hui, Jacob Schachter, Nethanel Asher, H. Helgadottir, Harvey Chai, Hidde Kroon, Brendon Coventry, Luke D. Rothermel, James Sun, Matteo S. Carlino, Zoey Duncan, Kristy Broman, Jeffrey Weber, Ann Y. Lee, Russell S. Berman, Jüri Teras, David W. Ollila, Georgina V. Long, Jonathan S. Zager, Alexander van Akkooi, Roger Olofsson Bagge
Publikováno v:
European Journal of Cancer. 169:210-222
Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option, despite the fact that there are no efficacy data available from prospective trials for exclusively ITM disease.
Autor:
Issac R. Schwantes, Thomas Sutton, Shay Behrens, Graham Fowler, Gang Han, John T. Vetto, Dale Han
Publikováno v:
The American Journal of Surgery.
Autor:
Raghav Tripathi, Karen Larson, Graham Fowler, Dale Han, John T. Vetto, Jeremy S. Bordeaux, Wesley Y. Yu
Publikováno v:
Annals of Surgical Oncology.
Autor:
Jackilen Shannon, Emily Ho, Philippe Thuillier, Karen Y. Oh, Arpana M. Naik, John T. Vetto, Paige E. Farris, Motomi Mori, Zhenzhen Zhang, Lauren L. Atwell
Supplementary Table 1. Basic characteristics of women in the study Supplementary Table 2. Incidence of reported grade 2 adverse events in the BroccoMax{trade mark, serif} trial (treatment-related) Supplementary Table 3. Sulforaphane (SFN) and SFN met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f76dca87db590282fcf6e75287705b
https://doi.org/10.1158/1940-6207.22524029.v1
https://doi.org/10.1158/1940-6207.22524029.v1
Autor:
Larry D. Dillon, Michael McPhee, Robert S. Davidson, Ann P. Quick, Brian Martin, Kyle R. Covington, Olga Zolochevska, Robert W. Cook, John T. Vetto, Abel D. Jarell, Martin D. Fleming
Publikováno v:
Current Medical Research and Opinion. 38:1267-1274
National Comprehensive Cancer Network (NCCN) guidelines for cutaneous melanoma (CM) recommend physicians consider increased surveillance for patients who typically have lower melanoma survival rates (stages IIB-IV as determined by the American Joint
Autor:
Raghav Tripathi, Karen Larson, Graham Fowler, Dale Han, John T. Vetto, Jeremy S. Bordeaux, Wesley Y. Yu
Publikováno v:
Annals of Surgical Oncology.